Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor Cells
Evangelia Pantazaka, Dimitrios Papakonstantinou, Argyro Roumeliotou, Dafni Graikioti, Sotirios Tsakas, Nefeli Zacharopoulou, Stuart S. Martin, Athanasios Kotsakis, Constantinos M. Athanassopoulos, Catherine Alix-Panabières, Galatea Kallergi · 2026
Read Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor Cells by Evangelia Pantazaka, Dimitrios Papakonstantinou, Argyro Roumeliotou, Dafni Graikioti, Sotirios Tsakas, Nefeli Zacharopoulou, Stuart S. Martin, Athanasios Kotsakis, Constantinos M. Athanassopoulos, Catherine Alix-Panabières, Galatea Kallergi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13223190.txt.
Description
Evangelia Pantazaka leads a team on artesunate against circulating tumor cells. Their study from twenty twenty-six deals with cells that drive cancer spread. Such cells shrug off standard cures, making them key targets.
Artesunate comes from artemisinin and shows cancer fight traits. It shifts marks tied to poor outlook in these cells. Breast, lung, and colon cell lines were all tested. A patient derived colon line was in the set as well. Cells from lung cancer patients were also checked. Life rates fell with dose and time in all lines.
Catalog record
| CREATOR | Evangelia Pantazaka, Dimitrios Papakonstantinou, Argyro Roumeliotou, Dafni Graikioti, Sotirios Tsakas, Nefeli Zacharopoulou, Stuart S. Martin, Athanasios Kotsakis, Constantinos M. Athanassopoulos, Catherine Alix-Panabières, Galatea Kallergi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |